home
December 2005 (full text): Treating HCV
with ribavirin analogues and ribavirin-like molecules
December
2005 (full text): Chronic
hepatitis C in patients with HIV-AIDS: a new challenge in antiviral therapy
December 2005 (full
text manuscript): The novel nucleoside analog R1479,
4'-azidocytidine, is a potent inhibitor of NS5B dependent RNA synthesis and HCV
replication in cell culture
December 2005 (full text
manuscript): Hepatitis C Virus Nonstructural
Proteins Inhibit Apolipoprotein B100 Secretion
December 2005 (full text): A
Significant Sex—but Not Elective Cesarean Section—Effect on Mother-to-Child
Transmission of Hepatitis C Virus Infection
2005:
Cryoglobulinemia
November 2005 (full
text manuscript): Binding Site Characterization and Resistance to a Class of
Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase
November 2005 (full text
manuscript): Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron
Transport and Increases Reactive Oxygen Species (ROS) Production
November 2005 (full text manuscript):
Functional Analysis of RNA Binding by the Hepatitis C Virus RNA-dependent RNA
Polymerase
November 2005 (full text):
Transmission of
Hepatitis C Virus to Several Organ and Tissue Recipients from an
Antibody-Negative Donor
October 2005 (full text): The spectrum of thyroid
dysfunction in an Australian hepatitis C population treated with combination
Interferon-alpha2beta and Ribavirin
October 2005 (full text manuscript): Binding-site characterization and
resistance to a class of non-nucleoside
inhibitors of the HCV NS5B polymerase
October 2005 (full text
manuscript): Intracellular vs. cell surface assembly of retroviral
pseudotypes is determined by the cellular localization of the viral
glycoprotein, its capacity to interact with Gag and the expression of the Nef
protein
October 2005
(full text manuscript): Hepatitis C virus nonstructural proteins inhibit
apolipoprotein B100
secretion
October 2005 (full text
manuscript): In vitro studies of cross-resistance mutations against two
hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061
October 2005 (full text): Milk Thistle
September-October 2005
(full text manuscript): Hepatitis
C virus core protein inhibits mitochondrial electron transport and increases ROS
production
September 2005 (full text
manuscript): Involvement of PKR and RNase L in translational control and
induction of apoptosis after Hepatitis C polyprotein expression from a Vaccinia
virus recombinant
September 2005 (full text manuscript):
Novel type I
interferon IL-28A suppresses hepatitis C viral RNA replication
August 2005 (full text):
Hepatitis C virus associated arthritis in
absence of clinical, biochemical and histological evidence of liver disease –
responding to interferon therapy
August 2005 (full text letter):
Testing for Hepatitis C Virus Infection
August (manuscript full text):
Interdomain communication in hepatitis C virus polymerase abolished by
small-molecule inhibitors bound to a novel allosteric site
August 2005 (manuscript full text):
Innate and Acquired Immune System in Patients Developing Interferon-alfa-Related
Autoimmune thyroiditis: A Prospective Study
July 2005: Hepatitis C virus NS2/3
processing is required for NS3 stability and viral RNA replication
July 2005: A universal BMV-based RNA recombination
system—how to search for general rules in RNA recombination
April 2005 (full text): Potential cellular
receptors involved in hepatitis C virus entry into cells
April 2005 (full text): Hepatic gene expression
profiles associated with fibrosis progression and
hepatocarcinogenesis in hepatitis C patients
April 2005 (full text): Effect of hepatitis C virus
nonstructural protein NS3 on proliferation and
MAPK phosphorylation of normal hepatocyte line
April 2005 (full text): Transforming growth factor-b1
gene polymorphisms are associated with
progression of liver fibrosis in Caucasians with chronic hepatitis C
infection
April 2005 (full text): The
liver-enriched transcription factor CREB-H is a growth suppressor protein
underexpressed in hepatocellular carcinoma
April 2005
(full text): Coffee, liver enzymes, cirrhosis and liver cancer
April
2005 (full text): Second Forum on Liver Transplantation Liver transplantation
for hepatitis C:
how to control the virus?
April
2005 (full text): The anhepatic phase of liver transplantation as a model for
measuring the
extra-hepatic replication of hepatitis C virus
April 2005 (full text): Proapoptotic and
pronecrosis effect of different truncated hepatitis C virus core proteins.
March 2005 (full
text): Plasma hydroxy-metronidazole/ metronidazole ratio in hepatitis C
virus-induced liver disease
March
2005 (full text): Molecular determinants of TRIF proteolysis mediated by
the hepatitis C virus NS3/4A protease
March 2005 (full text manuscript): Hepatitis C virus core protein
acts as a trans-modulating factor on internal translation initiation of the
viral RNA
March 2005 (full text): Characterizing
the function and structural organization of the 5' tRNA-like motif within the
hepatitis C virus quasispecies
March 2005 (full text): Translation of the F protein of hepatitis C
virus is initiated at a non-AUG codon in a +1 reading frame relative to the
polyprotein
March 2005 (full text): Liver biopsy 2005: When and how?
March
2005: Iron Inactivates the RNA
Polymerase NS5B and Suppresses Subgenomic
Replication of Hepatitis C Virus*
March
2005 (full text manuscript): Crystal structures of the RNA dependent RNA
polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest
mechanisms of inhibition by non-nucleoside inhibitors
February 2005 (full text manuscript):Replicative Homeostasis: A fundamental mechanism mediating selective viral replication and escape mutation
February 2005 (full text manuscript): Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA and virus infection
February 2005: Liver fibrosis
Januray 2005 (full text):Iloprost: an adjunctive approach to chronic viral hepatitis treatment
January 2005: Hemodynamics in the portal vein evaluated by pulse wave Doppler ultrasonography in patients with chronic hepatitis C treated with interferon
January 2005:
Decreased plasma adiponectin concentrations are closely related to steatosis in
HCV-infected patients
January 2005 (full text): Decreased plasma adiponectin concentrations are closely related to steatosis in
HCV-infected patients
January 2005 (full text manuscript):
Iron inactivates the RNA polymerase NS5B and suppresses subgenomic
replication of hepatitis C virus
January 2005 (full text manuscript): High density lipoproteins facilitate hepatitis C virus entry through the
scavenger receptor class B type I
January 2005 (full text manuscript):
Multiple full-length NS3 molecules are required for optimal unwinding of
oligonucleotide DNA in vitro
January 2005 (full text):
Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
January 2005 (full
text): Antibiotics...in Treatment of Hepatic Encephalopathy
home